Skip to main content
FDA approves setmelanotide for obesity in Bardet-Biedl syndrome
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA approves setmelanotide for obesity in Bardet-Biedl syndrome
User login
Username
Password
Reset your password
Specialty
Lead
score
Diabetes & Endocrinology
1
1
Family Medicine/Primary Care
0
0.8
Internal Medicine
0
0.7
Pediatrics
0
0.6
Pharmacist
0
0.5
Cardiology
0
0.9
Concept
Lead
score
Obesity
1
1
Food and Drug Administration (FDA)
0
0.99
Genomic Medicine
0
0.42
Body Mass Index
0
0.41
Genetic Disorders
0
0.97
Genetics
0
0.96
Pain Management
0
0.31
Genetic Testing
0
0.29
Child
0
0.98
Depression
0
0.25
Receptors
0
0.25
Low Birth Weight
0
0.18
Weight Management
0
0.18
Birth
0
0.17
Newborn
0
0.17
Penis
0
0.17
Abdominal Pain
0
0.14
Abdomen
0
0.08
Brain
0
0.08
Clinical Research
0
0.08
Hand
0
0.08
Kidney
0
0.08
Nausea
0
0.08
Nevus
0
0.08
Orphan Drugs
0
0.08
Pain
0
0.08
Pedal
0
0.08
Pigmentation
0
0.08
Diarrhea
0
0.06
Headache
0
0.06
Healthcare and Medical Technology
0
0.06
Edit Tags